Raludotatug Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with CDH6 Expressing Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancers Previously Treated with Bevacizumab
CAPVAXIVE® Demonstrates Positive Immune Responses in Children and Adolescents at Increased Risk of Pneumococcal Disease
life science investing BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. , BELLUS Health Inc , Prometheus Biosciences, Inc. , Univar Solutions Inc.
pharmaceutical investing Endo Begins Shipment of Authorized Generic Version of PROVENTIL HFA Inhalation Aerosol in the US
pharmaceutical investing Hemispherx Announces First Participant Received Initial Dosing in Breast Cancer Clinical Trial
Locksley Resources Announces Significant Expansion of its Exploration Program for both Rare Earths and Antimony After Increasing its Landholding to More than 40 Square Kilometers in California's Mojave Region
Blue Lagoon Announces Commissioning of MBBR Water Treatment System and Start of Underground Operations at Dome Mountain
